Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 09, 2017 06:00 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics to Announce Second Quarter Fiscal 2017 Results on February 13, 2017

RANCHO CORDOVA, Calif., Feb. 09, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cellular processing and point-of-care autologous cell-based therapies,...
January 17, 2017 06:00 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Appoints Dr. Joseph Thomis to Its Board of Directors

RANCHO CORDOVA, Calif., Jan. 17, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cellular processing and point-of-care autologous cell-based...
January 05, 2017 06:00 ET | Source: Cesca Therapeutics Inc.

Cesca Announces FDA Approval of IDE Supplement for Phase III Clinical Trial

RANCHO CORDOVA, Calif., Jan. 05, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cellular processing and point-of-care autologous cell-based therapies,...
January 03, 2017 06:00 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics to Present at the 9th Annual Biotech Showcase

RANCHO CORDOVA, Calif., Jan. 03, 2017 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cellular processing and point-of-care autologous cell-based...
December 05, 2016 06:00 ET | Source: Cesca Therapeutics Inc.

Cesca Submits IDE Supplement for CLI Pivotal Trial

RANCHO CORDOVA, Calif., Dec. 05, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cellular processing and point-of-care autologous cell-based...
December 02, 2016 06:00 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics to Present at the 9th Annual LD Micro Main Event

RANCHO CORDOVA, Calif., Dec. 02, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cellular processing and point-of-care autologous cell-based...
November 17, 2016 16:05 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Reports First Quarter Fiscal 2017 Results and Provides Business Update

RANCHO CORDOVA, Calif., Nov. 17, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cellular processing and point-of-care autologous cell-based...
November 16, 2016 06:00 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics to Announce First Quarter Fiscal 2017 Results on November 17, 2016

RANCHO CORDOVA, Calif., Nov. 16, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), a market leader in automated cellular processing and point-of-care autologous cell-based...
October 18, 2016 06:00 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics Granted Third U.S. Patent Relating to Its Proprietary SurgWerks™ Platform

RANCHO CORDOVA, Calif., Oct. 18, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that the United States...
September 27, 2016 06:00 ET | Source: Cesca Therapeutics Inc.

Cesca Therapeutics to Present & Exhibit at the ISCT North America 2016 Regional Meeting

RANCHO CORDOVA, Calif., Sept. 27, 2016 (GLOBE NEWSWIRE) -- Cesca Therapeutics Inc. (NASDAQ:KOOL), an autologous cell-based regenerative medicine company, today announced that Dalip Sethi, Ph.D.,...